Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Fucoxanthin inhibits the proliferation and stem cell formation of oral squamous cell carcinoma (OSCC) cells by regulating JAK/STAT3 pathway

Xue Feng1, Yu Li2, Lijia Zhang2, Heng Sun2, Songjiang Liu2

1Department of Oncology, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province 150006, China; 2Department of Oncology, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province 150006, China.

For correspondence:-  Songjiang Liu   Email: zyylsj@163.com   Tel:+8613104611913

Accepted: 25 December 2022        Published: 30 January 2023

Citation: Feng X, Li Y, Zhang L, Sun H, Liu S. Fucoxanthin inhibits the proliferation and stem cell formation of oral squamous cell carcinoma (OSCC) cells by regulating JAK/STAT3 pathway. Trop J Pharm Res 2023; 22(1):9-14 doi: 10.4314/tjpr.v22i1.2

© 2023 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the effect and regulatory mechanism of fucoxanthin (FX) on oral squamous cell carcinoma (OSCC).
Methods: Human OSCC SCC9 and Cal27 cells were treated with different concentrations of FX (7.5, 15, and 30 μM) to determine cell viability, number of colonies, and apoptosis rate using methyl thiazolyl diphenyl-tetrazolium bromide (MTT) assay, crystal violet staining, and flow cytometry, respectively. In addition, the number of spheres of OSCC cells was determined by a cell sphere-forming assay. The stem cells and levels of pathway-related proteins were evaluated by western blotting.
Results: Fucoxanthin decreased SCC9 and Cal27 cell viability and the number of colonies, but increased apoptosis in a dose-dependent manner. The expression levels of SOX2 and POU5F1 were down-regulated, while the number of spheres was reduced in SCC9 and Cal27 cells treated with 7.5 or 15 μM of FX (p < 0.05). Moreover, FX attenuated p-JAK/JAK and p-STAT3/STAT3 expression levels in a dose-dependent manner (p < 0.05).
Conclusion: Fucoxanthin accelerates apoptosis and inhibits cell mobility and OSCC stem cell formation by suppressing JAK/STAT3 pathway in OSCC, thus providing an experimental basis for research on the anti-tumor effect of kelp extract and the development of new drugs from marine plants.

Keywords: Fucoxanthin (FX), Oral squamous cell carcinoma (OSCC), JAK/STAT3 pathway, Tumor stem cell, Apoptosis

Impact Factor
Thompson Reuters (ISI): 0.6 (2023)
H-5 index (Google Scholar): 49 (2023)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal:

Archives

2024; 23: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10
2023; 22: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2022; 21: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2021; 20: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2020; 19: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2019; 18: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2018; 17: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2017; 16: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2016; 15: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2015; 14: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2014; 13: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2013; 12: 
1,   2,   3,   4,   5,   6
2012; 11: 
1,   2,   3,   4,   5,   6
2011; 10: 
1,   2,   3,   4,   5,   6
2010; 9: 
1,   2,   3,   4,   5,   6
2009; 8: 
1,   2,   3,   4,   5,   6
2008; 7: 
1,   2,   3,   4
2007; 6: 
1,   2,   3,   4
2006; 5: 
1,   2
2005; 4: 
1,   2
2004; 3: 
1
2003; 2: 
1,   2
2002; 1: 
1,   2

News Updates